| 000 | 01456 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513203612.0 | ||
| 264 | 0 | _c20000621 | |
| 008 | 200006s 0 0 eng d | ||
| 022 | _a0168-3659 | ||
| 024 | 7 |
_a10.1016/s0168-3659(99)00220-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarra, J | |
| 245 | 0 | 0 |
_aModified drug release from inert matrix tablets prepared from formulations of identical composition but different organisations. _h[electronic resource] |
| 260 |
_bJournal of controlled release : official journal of the Controlled Release Society _cApr 2000 |
||
| 300 |
_a419-28 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aCellulose _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aDrug Compounding _xmethods |
| 650 | 0 | 4 | _aElectron Probe Microanalysis |
| 650 | 0 | 4 | _aMicroscopy, Electron, Scanning |
| 650 | 0 | 4 |
_aNiflumic Acid _xadministration & dosage |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 | _aPharmaceutical Vehicles |
| 650 | 0 | 4 | _aPorosity |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aSurface Properties |
| 650 | 0 | 4 | _aTablets |
| 650 | 0 | 4 | _aViscosity |
| 700 | 1 | _aFalson-Rieg, F | |
| 700 | 1 | _aDoelker, E | |
| 773 | 0 |
_tJournal of controlled release : official journal of the Controlled Release Society _gvol. 65 _gno. 3 _gp. 419-28 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0168-3659(99)00220-5 _zAvailable from publisher's website |
| 999 |
_c10653403 _d10653403 |
||